Every intervention Outliyr has scored for focus and mental clarity, ranked by its BioHarmony score for this use case rather than its overall rating. The number beside each name is how well that one thing works for focus and mental clarity; the tier beside it is what it is worth once safety, cost and effort are counted across everything else.
83 of 129 evaluated interventions score 3.0+ out of 10 for focus and mental clarity · 20 comparisons
Neurofeedback scores 8.0/10 for cognition focus, with the best signal coming from Westwood et al. 2025. Attention remains one of neurofeedback's best-known use cases, but the claim needs caveats. Arns 2009 reported…
Read the Neurofeedback report →For readers prioritizing cognition focus, L-Theanine scores 7.5/10 today. Caffeine-stack synergy is the main evidence base: Owen 2008, Giesbrecht 2010, Kelly 2008, and Haskell 2008 support attention and reaction-time benefits. Mátyus 2025…
Read the L-Theanine report →Lion's Mane cognition focus earns 7.0/10 because Mori 2009 anchors the most relevant signal. Lion's Mane fits cognition focus when the goal is gentle mushroom-based support for cognition, mood, nerve biology, or…
Read the Lion’s Mane report →The cognition-focus case for Methylene Blue is 6.8/10 because Ramsay 2007 gives the most relevant evidence anchor. The existing rationale points to this narrower claim: Acute focus claims are supported mainly by…
Read the Methylene Blue report →Evidence for Creatine Monohydrate in cognition and focus lands at 6.6/10 because Dolan 2019 reports Brain creatine and cognitive processing review. Avgerinos 2018 points in the same direction, but route, dose, baseline…
Read the Creatine Monohydrate report →Magnesium cognition focus earns 6.6/10 because de Baaij 2015 anchors the most relevant signal. Magnesium fits cognition focus when low intake, stress load, mineral loss, or a form-specific target makes deficiency correction…
Read the Magnesium report →The evidence-weighted call is 6.5/10 for HRV Biofeedback in cognition focus, led by Lehrer et al. 2004. Several small trials show improved attentional performance and inhibitory control with RF training, though Rosendo…
Read the HRV Biofeedback report →The cognition-focus case for Electrolytes is 6.5/10 because Sacks 2001 gives the most relevant evidence anchor. The existing rationale points to this narrower claim: this verified source found mild dehydration worsened mood,…
Read the Electrolytes report →The cognition-focus case for Zone 2 Cardio is 6.5/10 because Lang 2024 gives the most relevant evidence anchor. The existing rationale points to this narrower claim: Aerobic exercise is one of the…
Read the Zone 2 Cardio report →Taurine earns 6.5/10 for cognition and focus because Tzang 2024 reports 25 RCTs and 1024 participants; lower SBP, DBP, fasting blood glucose, and triglycerides; no significant adverse-effect excess. Tzang 2024 points in…
Read the Taurine report →Cognition-focus earns 6.5/10 because Naeser 2011 reported cognitive improvements after transcranial red and near-infrared LED treatments in chronic mild TBI. That is promising, but it is not broad proof for healthy focus…
Read the Red Light Therapy report →For cognition focus, Phosphatidylserine lands at 6.5/10 because Friling et al. 2025 supports the core mechanism. FDA qualified claim status and older AAMI trials support targeted cognition use in elderly adults. Crook…
Read the Phosphatidylserine report →Semax earns 6.5/10 for cognition focus; this is a targeted fit score. The best human cognitive signal is Russian attention and operative-memory work, including Asmarin et al. 1997 and Kaplan et al.…
Read the Semax report →Cognition Focus is a 6.5/10 fit for Tesamorelin, based on the evidence summarized in Falutz et al. 2008. The cognition signal comes mainly from Baker 2012, which reported improved cognitive function in…
Read the Tesamorelin report →For cognition focus, Modafinil earns 6.5/10 because the evidence points to a plausible use case without proving a universal response. Muller U et al. 2013 is the best anchor here because it…
Read the Modafinil report →Older-adult cognition trials and chronic neurorehab studies justify a meaningful score. Hadanny 2020 reports gains in attention, processing speed, and executive function after sixty hard-chamber sessions. The effect is protocol-heavy and not…
Read the Hyperbaric Oxygen Therapy report →Infrared Sauna's 6.3/10 cognition-focus score starts with Oosterveld 2009, then gets narrowed by the evidence gap. The existing rationale points to this narrower claim: Cognition support comes mostly from sauna-bathing cohort data…
Read the Infrared Sauna report →Rapamycin cognition focus earns 6.0/10 because Harrison 2009 anchors the most relevant signal. Rapamycin fits cognition focus when mTORC1 modulation, autophagy, immune aging, or senescence biology is the actual target. The score…
Read the Rapamycin report →Paraxanthine scores 6.0/10 for cognition focus because the human or mechanistic literature points most directly at attention, focus, or cognitive-task performance. The strongest support comes from Yoo C. et al. 2021, but…
Read the Paraxanthine (Enfinity) report →Molecular Hydrogen earns 5.8/10 for cognition and focus because Nishimaki 2018 reports MCI RCT; cognitive signal appeared strongest in APOE4 carriers. The score stays conditional because Molecular Hydrogen still needs better outcome…
Read the Molecular Hydrogen report →The evidence-weighted call is 5.8/10 for Vagus Nerve Stimulation in cognition focus, led by Conway et al. 2025. Kong 2024 found no significant overall cognitive improvement in epilepsy patients despite seizure, mood,…
Read the Vagus Nerve Stimulation report →Cognition and focus lands at 5.8/10. Long-term flavonoid intake associates with less subjective cognitive decline in large cohorts, and cocoa flavanols acutely improve cerebral blood flow and have shown small working-memory and…
Read the Polyphenols (Dietary) report →Cognition support is biologically plausible but lacks a dedicated cognitive-battery RCT. The Voznesenskaia 2010 multicenter trial captured concentration and attention improvement inside the asthenia outcome rather than as a primary endpoint. The…
Read the Bromantane (Ladasten) report →Mechanistically, Time-Restricted Eating scores 5.8/10 for cognition focus because the evidence points to a plausible use case without proving a universal response. Chen X et al. 2026 is the best anchor here…
Read the Time-Restricted Eating report →Ca-AKG (Calcium Alpha-Ketoglutarate)'s 5.6/10 cognition-focus score starts with Demidenko 2021, then gets narrowed by the evidence gap. The existing rationale points to this narrower claim: this verified source supports hippocampal LTP rescue…
Read the Ca-AKG (Calcium Alpha-Ketoglutarate) report →Mechanistically, Saffron scores 5.5/10 for cognition focus because the evidence points to a plausible use case without proving a universal response. D'Onofrio et al. 2021 is the best anchor here because it…
Read the Saffron report →Mechanistically, Astaxanthin fits cognition and focus at 5.5/10 because Liu 2024 reports 11 RCTs; 346 healthy participants; significant improvements reported across fatigue, cognition, and exercise-efficiency endpoints overall; endpoint details are limited. The…
Read the Astaxanthin report →Cognition and focus reach 5.5/10 on early, mixed interventional data. Zajac 2025, the largest human trial at 147 older adults with subjective memory complaints, found dose-dependent gains in subjective prospective memory and…
Read the Ergothioneine report →Population fit explains the 5.5/10 cognition focus score for Ketogenic Diet because the evidence points to a plausible use case without proving a universal response. Leung GKW et al. 2025 is the…
Read the Ketogenic Diet report →Sabroxy scores 5.5/10 for cognition focus because the human or mechanistic literature points most directly at attention, focus, or cognitive-task performance. The strongest support comes from Dinda B. et al. 2015, but…
Read the Sabroxy (Oroxylum indicum Extract) report →Senolytics has a 5.5/10 cognition focus case because Xu et al. 2018 supports a plausible benefit. Gonzales 2023 was a 5-person Alzheimer's feasibility trial of D+Q; it supports CNS-penetrance questions, not cognitive…
Read the Senolytics report →The evidence for Resveratrol's cognition-focus use case scores 5.5/10, based on a 24-month randomized, double-blind, placebo-controlled crossover trial in postmenopausal women Thaung Zaw 2020. That study reported modest improvements in cognitive tests…
Read the Resveratrol report →The evidence supporting Tirzepatide for the cognition-focus use case rates 5.2/10, reflecting that no primary human cognition trial has been audit-verified (see Franco 2025). Tirzepatide and the cognition-focus label rely on observational…
Read the Tirzepatide report →Phenylpiracetam scores 5.2/10 for cognition focus because the human or mechanistic literature points most directly at attention, focus, or cognitive-task performance. The strongest support comes from Malykh A. et al. 2010, but…
Read the Phenylpiracetam (Phenotropil) report →The Norwegian 4x4 protocol scores 5.0/10 for the cognition-focus use case, and a landmark trial reported a 7.2% increase in VO2max after the 4 x 4 regimen Helgerud 2007. Norwegian 4x4 aims…
Read the Norwegian 4×4 report →Glycine cognition focus earns 5.0/10 because Soh 2024 anchors the most relevant signal. Glycine fits cognition focus because glycine participates in sleep signaling, glutathione, collagen, methylation, and nervous-system balance, depending on the…
Read the Glycine report →Cognition scores 5.0/10, and the distinction here matters. The strong dementia and Alzheimer association from Laukkanen 2017 is a long-term, disease-prevention protective signal driven largely by better cardiovascular and vascular health, not…
Read the Traditional Sauna (Finnish Dry-Heat) report →The cognition focus score is 5.0/10, and PEMF (Pulsed Electromagnetic Field Therapy) needs careful framing. Cranial application has mixed evidence and wellness cognition claims remain unproven. PEMF is not a reliable nootropic.…
Read the PEMF (Pulsed Electromagnetic Field Therapy) report →Cognition-focus receives a 5.0/10 score for Metformin because observational diabetes cohorts suggest possible dementia-risk reduction, but causality remains uncertain Bannister 2014. Metformin's cognition case is strongest when improved glucose control reduces vascular…
Read the Metformin report →For cognition focus, Ashwagandha earns 5.0/10 because the evidence points to a plausible use case without proving a universal response. Zhu et al. 2026 is the best anchor here because it reports…
Read the Ashwagandha report →Cognition scores 5.0/10 on the strength of the pilot signal. Kumar 2021 reported improved cognitive test scores and verbal fluency in older adults over 24 weeks, declining after stopping. This is a…
Read the GlyNAC (Glycine + N-Acetylcysteine) report →Piracetam scores 5.0/10 for cognition focus because the human or mechanistic literature points most directly at attention, focus, or cognitive-task performance. The strongest support comes from Cohen P. et al. 2020, but…
Read the Piracetam (Nootropil) report →Aniracetam scores 5.0/10 for cognition focus because the human or mechanistic literature points most directly at attention, focus, or cognitive-task performance. The strongest support comes from Isaacson et al. 1991, but the…
Read the Aniracetam report →Oxiracetam scores 5.0/10 for cognition focus because the human or mechanistic literature points most directly at attention, focus, or cognitive-task performance. The strongest support comes from Copani A. et al. 1992, but…
Read the Oxiracetam report →Cognition-focus stays at 5.0/10 because Semaglutide has interesting brain biology but no decisive human focus trial in this report. Yao 2024 supports metabolic improvements that can indirectly help cognition in diabetes or…
Read the Semaglutide report →Dynamine scores 5.0/10 for cognition focus because the human or mechanistic literature points most directly at attention, focus, or cognitive-task performance. The strongest support comes from Cintineo H. et al. 2022, but…
Read the Dynamine (Methylliberine) report →The cognition focus score is 5.0/10, and Ephedrine needs careful framing. Adrenergic-driven alertness and reaction time benefit at acute doses; Sidney and Lefcoe 1977 found no benefit on reaction time, hand-eye coordination,…
Read the Ephedrine report →Dihexa cognition focus earns 5.0/10 because McCoy 2013 anchors the most relevant signal. Dihexa fits cognition focus only as a research-chemical hypothesis around synaptogenesis and memory circuits, not as a proven human…
Read the Dihexa report →Mechanistic interest via glutathione and glutamate modulation, but no strong direct cognition RCT base in healthy adults. Neuroprotective framing is mostly preclinical.
Read the NAC (N-Acetylcysteine) report →Schwarz 2022 SmartAge found no significant primary memory benefit after 12 months, though exploratory signals kept cognition from scoring lower.
Read the Spermidine report →No direct cognitive RCTs outside neurological rehab context. Any cognitive benefit would be secondary to movement, mood, or Parkinson's motor support.
Read the Whole-Body Vibration report →Cognition is a weak case at 4.5/10. The antioxidant and mitochondrial rationale is plausible for neurodegeneration, but large trials in Parkinson and Huntington disease were largely negative, and there is no convincing…
Read the Coenzyme Q10 (CoQ10 / Ubiquinol) report →Selank looks more cognition-preserving than cognition-transforming. Human comparator studies describe mild nootropic or antiasthenic effects, while preclinical work such as Semenova 2007 supports learning under brain-stress models.
Read the Selank report →Higher aerobic fitness supports cerebral blood flow and BDNF, but the cognition evidence for sprint training specifically is indirect and derived mainly from broader fitness studies.
Read the Sprinting (Sprint Interval Training) report →Cognition evidence is mixed. The audit could not verify the claimed VITAL omega-3 cognition source, so cognition scoring leans on narrower memory data such as Yurko-Mauro 2010 rather than broad prevention claims.
Read the Omega-3 report →The cognitive case is widely overstated. Acute effects in healthy adults are small and mostly appear under fatigue: Evans 2018 found a ketone ester attenuated executive-function decline only after exhausting exercise. The…
Read the Exogenous Ketones report →Preserved v0.x score. No verified healthy-cognition ozone RCT was available in the audit, while neurological harm signals are concrete for gas routes. Khosravi 2024 reported cerebral gas embolism and multifocal ischemic stroke…
Read the Ozone Therapy report →Cognition is the most-claimed and best-studied use, but the human signal is real and contested at once, so it scores moderate rather than high. In mild-to-moderate Alzheimer's, pooled trials showed a cognitive…
Read the Cerebrolysin report →No direct cognition or focus benefit was verified. Tryptophan and tyrosine share large neutral amino acid transport with other EAAs, so neurotransmitter claims should stay modest.
Read the Essential Amino Acids report →Observational data link 25(OH)D status to cognitive function, but D3 supplementation RCTs are largely null on cognitive endpoints in healthy or mild cognitive impairment populations. The DO-HEALTH trial (Bischoff-Ferrari et al. 2020…
Read the Vitamin D3 + K2 report →Cognition scores 4.0/10. Deficiency can impair mood and mental clarity, and these improve with repletion, but there is little evidence that supplementing beyond adequacy sharpens focus or cognition in healthy adults. Vitamin…
Read the Vitamin C (Ascorbic Acid) report →Cognition remains a 4 because evidence is preclinical or indirect. Tucker 2024 reported attenuation of Alzheimer's-like features in mice, and Pickart 2012 discusses cognitive-health mechanisms, but human focus data is absent.
Read the GHK-Cu report →Neuroprotective effects may support cognitive function indirectly in injury models. There is no direct healthy-adult focus trial, so cognition claims should remain conservative.
Read the BPC-157 report →Indirect. Aerobic fitness associates with better cognition over time, but no rucking-specific cognitive data exists; this rides the general aerobic-exercise literature.
Read the Rucking (Weighted Walking) report →Cognition has no human trial of Tβ4. The rat TBI cognitive improvements, per Xiong 2011, are TBI-recovery findings, not healthy-cognition data.
Read the Thymosin Beta-4 (Tβ4) report →Mood and arousal changes may improve perceived focus in some stressed users. No direct cognitive RCTs, attention endpoints, or memory endpoints justify stronger claims.
Read the Tongkat Ali report →One 18-month RCT using Theracurmin (Small and colleagues 2018, n=40) showed memory and attention benefits, but a 2025 dose-response meta-analysis found effects only emerge around 0.8 g per day over at least…
Read the Curcumin report →At low doses kava does not appear to impair acuity, but it is not a cognitive enhancer. Higher doses sedate. No focus or cognition trials support a positive score.
Read the Kava (Piper methysticum) report →No direct cognitive evidence supports BFR as a focus intervention.
Read the Blood-Flow Restriction Training report →Carrasco-Gallardo 2012 summarizes tau-aggregation and neuroprotection mechanisms, but shilajit-alone human cognition RCTs are absent.
Read the Shilajit report →Resistance training can improve executive function through exercise-mediated pathways, but EMS-specific cognitive trials are lacking. Any focus benefit is likely indirect through improved training adherence, mood, and metabolic health.
Read the Full-Body EMS report →No human cognition-focus trial exists. Any cognitive rationale depends on immune-brain signaling and illness recovery, not direct nootropic evidence.
Read the Thymosin Alpha-1 report →No meaningful human cognition trials for spirulina; any benefit would be indirect via metabolic and vascular health.
Read the Spirulina report →Animal and mechanistic models suggest BBB penetration and possible neuroprotective signaling, but there are no strong human cognition RCTs. Any subjective focus effect is more likely from better glucose control in dysregulated…
Read the Berberine report →Yankouskaya 2023 Biology fMRI study (n=33) showed 5 min head-out 20 degC immersion altered coupling between default-mode, frontoparietal, and salience networks, with self-reported gains in alertness and attentiveness. Acute focus lift is…
Read the Cold Plunge report →Cognitive evidence remains preclinical or indirect. Rajman 2018 summarizes NAD-booster biology, but no completed human NMN cognitive RCT establishes benefit.
Read the NMN (Nicotinamide Mononucleotide) report →No cognition or focus RCT supports glutathione supplementation; the Parkinson trials targeted motor symptoms and were null on controlled endpoints. Scores 3.0/10.
Read the Glutathione (GSH) report →Wu 2025 found NAD+ rose 2.6- to 3.1-fold in long-COVID, but cognition, fatigue, sleep, anxiety, and depression did not significantly improve versus placebo.
Read the NR (Nicotinamide Riboside) report →The brain is mitochondria-dependent, but no verified human cognition RCT for SS-31 supports a higher score. This remains a mechanism-derived, not clinically proven, use case.
Read the SS-31 (Elamipretide) report →Anti-neuroinflammatory effects could matter in selected inflammatory states, but Alzheimer prevention work was inconclusive or halted. Celecoxib is not a cognitive enhancer.
Read the Celebrex (Celecoxib) report →Memory improved in the D-galactose mouse model, but no human cognition trial supports a focus or memory claim.
Read the Pine Pollen report →TRT is weak for cognition. The T Trials cognition substudy found no meaningful improvement in memory or executive function in older men with low testosterone and age-associated memory impairment.
Read the TRT (Testosterone Replacement Therapy) report →No randomized trial has tested C15:0 supplementation for memory, attention, executive function, dementia prevention, or mood. Ciesielski 2024 (Ciesielski 2024) discusses emerging biology but does not establish a cognitive indication. The v0…
Read the C15 (Pentadecanoic Acid) report →Nothing matches those filters.
Head-to-head reports and category rankings that name a winner on this use case.
Bromantane and semax tie at 7.1, and they are the only two in this category scored strong recommend. Selank is third at 6.9 if anxiety rather than focus…
Melatonin, dosed low. It scores 8.2 against apigenin's 6.7 and wins the sleep rows outright. The morning hangover apigenin markets against comes from taking too much, not from…
Both score anxiety 7.5, so the tie-breaker is time. L-theanine works in about an hour and you take it when you need it. Ashwagandha takes eight weeks and…
Bromantane, for anything you plan to repeat. It scores 7.1 against phenylpiracetam's 5.5 and wins every shared use case that is not a floor tie: energy 6.2 to…
Cerebrolysin scores 6.3 and P-21 scores 5.0, and the gap is entirely about human data. Cerebrolysin has thousands of trial participants, contested by two independent Cochrane reviews. P-21…
CoQ10 scores 7.1 and methylene blue 6.1, yet methylene blue wins eleven of the seventeen shared use cases. The overall gap is risk, not effect. Methylene blue inhibits…
Neither, yet. Both have zero human trials, zero human pharmacokinetics and research-only access. PE-22-28 scores 4.9 and dihexa 4.4, and the gap is entirely safety: dihexa potentiates the…
Epitalon, if sleep is the question. It scores sleep quality 6.5 against pinealon's 1.7, because it acts on the pineal gland and melatonin output while pinealon is a…
No, and the reason is mechanical. A drink raises blood ketones in an hour. It does not lower insulin, deplete glycogen or shift fuel use. The diet scores…
Buy the panel. Red light therapy scores 8.0 against HBOT's 6.2, costs $17 to $43 a month against $3,000 to $6,000, and does not lose a single use…
Lion's Mane scores 7.2 and the reishi, cordyceps and chaga blend category scores 5.8. If cognition is the goal, buy the one species: lion's mane takes cognition-focus 7.0…
They solve different problems and the scores hide that. Oxytocin scores 6.5 against PT-141's 5.4, mostly on safety and cost. PT-141 still wins libido 5.5 against 2.5. Oxytocin…
Neurofeedback, at 8.0 out of 10 for focus and mental clarity. Neurofeedback scores 8.0/10 for cognition focus, with the best signal coming from Westwood et al.
Of the top-scoring options, L-Theanine is the least expensive at about $3 a month, scoring 7.5 out of 10 for focus and mental clarity.
Dihexa scores 5.0 out of 10 for focus and mental clarity but only 4.4 overall, landing in the caution tier once safety, side effects, cost and effort are counted.
83 of the 129 interventions evaluated for focus and mental clarity score 3.0 out of 10 or better, which is the cut-off for appearing on this page.
